AzTrials
AzTrials

Upper Limb WoundNCT04992351

Wide-awake Local Anesthesia and no Tourniquet (WALANT) in Plastic Surgery

An observational study of Upper Limb Wound and Lower Limb Wound, run by University Hospital, Ioannina at 1 site in Greece.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Wide-awake local anesthesia no tourniquet (WALANT) was proposed and performed in hand operations. Aim of this study is to present the use of WALANT in operations performed on the upper and lower limbs, evaluate its efficacy in terms of feasibility, total operation time, total operating room time, bleeding, patient… Read more about this study

Who is it for?
Ages 14 years and older
What is being tested?
WALANT
Type of treatment
Surgery or procedure
How many people
90 participants
Where
1 siteGreece
Study dates
1 Jun 2019to 5 May 2023
How long will I take part?
8 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: patients who undergo general plastic surgery operations in the upper or lower limb

Who may be able to join

  • upper or lower limb operation
  • indication for flap or skin grafting
  • operated by the principal investigator

Who cannot join

  • other concomitant operations performed
  • known allergy to any of the ingredients of local anesthesia mixture

Trial locations and contacts

1 site in 1 country.

Greece1 site
  • Plastic Surgery Department

    Ioannina

Other trials in Greece

About this study

Official title: Wide-awake Local Anesthesia and no Tourniquet (WALANT) in Plastic Surgery: Indications, Clinical Applications and Outcomes

Wide-awake local anesthesia no tourniquet (WALANT) was proposed and performed in hand operations.

Aim of this study is to present the use of WALANT in operations performed on the upper and lower limbs, evaluate its efficacy in terms of feasibility, total operation time, total operating room time, bleeding, patient discomfort and satisfaction and control for potential drawbacks. The hypothesis is that WALANT is a viable option in common operations performed by plastic surgeons on the upper and lower limbs.

Read the detailed description

Wide-awake local anesthesia no tourniquet (WALANT) was proposed and performed in hand operations. Little has been studied, regarding its indications and efficacy in general plastic surgery operations.

Aim of this study is to present the use of WALANT in operations performed on the upper and lower limbs, evaluate its efficacy in terms of feasibility, total operation time, total operating room time, bleeding, patient discomfort and satisfaction and control for potential drawbacks. The hypothesis is that WALANT is a viable option in common operations performed by plastic surgeons on the upper and lower limbs.

A prospective study will be conducted comparing the use of WALANT in operations performed on the upper and lower limbs to the traditional use of tourniquet with general or regional anesthesia.

Being tested
WALANT
Keywords
WALANT, plastic surgery, upper limb, lower limb

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WALANTProcedure or surgery

    WALANT as anesthesia method for upper and lower limb palstic surgery operations

Study groups in NCT04992351
Study groupRoleWhat they receive
WALANT groupWALANT was used exclusively as anesthesia method for the operation
Receives: Procedure: WALANT
controltourniquet with regional or general anesthesia was used for the operation
Receives: Procedure: WALANT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. total operation time

    the difference between skin incision and skin closure in minutes

    Measured: through operation completion

  2. operation theatre time

    the difference between entry and exit of the patient from the operation theatre in minutes

    Measured: through operation completion with exit from the operation theatre

  3. Patient satisfaction

    estimated by a 10-point visual analogue scale (1-10, 10 is the best outcome)

    Measured: at 8 weeks

  4. feasibility of the WALANT method

    percentage of cases, which could not be completed under WALANT with conversion to the traditional method of anesthesia

    Measured: through operation completion

Secondary outcomes (1)
  1. complications

    number and type of complications in each group

    Measured: at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2021
  2. Study start1 Jun 2019
  3. Primary completion10 Oct 2022
  4. Study completion5 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
90 participants (actual)
Target duration
8 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT04992351
Sponsor's protocol ID
11335
Status last verified
May 2024
First submitted
13 Jul 2021
Last updated
8 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Upper Limb Wound and Lower Limb Wound, run by University Hospital, Ioannina at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

total operation time (time frame: through operation completion). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in